Adidas’ strong market momentum may be slowing after weaker-than-expected second-quarter results raised doubts over the durability of its turnaround. The sportswear giant reported a softer Q2 revenue, hit by sluggish direct-to-consumer sales, slower footwear demand, and ongoing challenges in Europe.
Investors worry the surge fueled by Adidas’ popular Terrace line and refreshed brand image may be fading. However, UBS says it’s too early to call the end of the company’s outperformance. While Terrace-driven growth has moderated, new product franchises are emerging to fill the gap. With product launches typically taking up to nine months to gain traction, UBS expects stronger contributions in the second half of the year.
Europe, the weakest region in Q2, may already be recovering, with July sales showing improvement and retailer sentiment staying optimistic. The U.S. remains a drag, but Adidas reiterated its outlook for double-digit growth across all other markets, representing roughly 80% of total sales. Foreign exchange hedging is also expected to support earnings through 2026.
UBS cautions that Q3 will be the key test for momentum. If new franchises can offset the slowdown in Terrace, the turnaround story could continue. At around 24 times 2025 earnings, Adidas is trading below the growth implied by its long-term guidance. UBS maintains a Buy rating with a €274 price target but warns that another weak quarter could quickly shift sentiment.
With brand renewal efforts underway and global demand pockets still strong, the coming months will determine whether Adidas can sustain its growth trajectory or face a sharper slowdown. For now, UBS believes patience is warranted, as the second half could still deliver for investors.


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



